Protégé™ GPS™ SERB65-10-80-120 (UDI 00821684071571)Recalls & reported problems
Ev3, Inc · STENT SERB65-10-80-120 PROTEGE GPS V05 · Class 3 · Implant
All models of Protégé GPS (26)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 1
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00821684071571), received between May 17, 2017 and Jun 27, 2018 — classified as 1 death, 2 malfunctions.
The most frequently reported specific device problem is “Detachment of Device or Device Component” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Detachment of Device or Device Component2
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- No Consequences Or Impact To Patient2
- Death1
- Perforation1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
DeathJun 27, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE PATIENT IN THIS INCIDENT HAD A TOTAL RIGHT PROXIMAL TO MID ILIAC OCCLUSION THAT WAS APPROACHED RETROGRADE ON THE RIGHT SIDE. THE VESSEL WAS PRE-DILATED. THE TARGET LESION WAS A CTO (CHRONIC TOTAL OCCLUSION-100%) WITH SEVERE CALCIFICATION. THE VESSEL WAS MODERATELY TORTUOUS. A VIANCE CATHETER WAS INITIALLY USED TO TRY AND CROSS THE LESION BUT WENT SUB-INTIMAL AND POTENTIALLY OUTSIDE THE VESSEL IN THIS ATTEMPT BELOW THE OCCLUSION. A GUIDE WIRE AND RE-ENTRY CATHETER WERE USED SUCCESSFULLY TO EVENTUALLY NAVIGATE PAST THE LESION AND RE-ENTER THE ILIAC. TREATMENT TO THE PROXIMAL RIGHT ILIAC THEN WAS ORIGINALLY APPROACHED WITH THE THOUGHT IN MIND OF USING A PROTÉGÉ GPS ON THE OSTIAL AND PROXIMAL ILIAC WITH THE GOAL OF NOT COMPROMISING OR JAILING THE INTERNAL ILIAC. A 10X80 PROTÉGÉ GPS WAS DEPLOYED SUCCESSFULLY. AN EVERFLEX 8X80 WAS USED TO TREAT A STENOSIS ON THE LEFT ILIAC SUCCESSFULLY AS WELL. IT WAS THEN NOTED THE PATIENT¿S BLADDER LOOKED COMPRESSED, A TYPICAL SIGN OF AN INTERNAL BLEEDING SITUATION. A NON-MDT COVERED STENT WAS PLACED DISTAL TO THE 10X 80 PROTÉGÉ IN THE RIGHT ILLIAC WHERE THE BLEED APPEARED TO BE AND THIS SEEMED TO RESOLVE THE ISSUE. UPON FURTHER EXAMINATION O
Patient problems: Death; Perforation
MAUDE report 7640839 ↗MalfunctionMay 17, 2017Detachment of Device or Device Component; Detachment of Device or Device Component
THE PHYSICIAN WAS ATTEMPTING TO USE A PROTÉGÉ GPS STENT TO TREAT AN UNKNOWN LESION. THE DEVICE WAS PREPPED AS PER IFU WITHOUT ISSUE. NO RESISTANCE WAS ENCOUNTERED WHEN ADVANCING THE DEVICE AND NO EXCESSIVE FORCE WAS USED THE THUMBSCREW/LOCK-PIN WAS CHECKED FOR MEASUREMENT PRIOR TO PROCEDURE. PRIOR TO ATTEMPTING TO DEPLOY THE STENT, WHEN UNSCREWING THE PIN PULL DEPLOYMENT, IT WAS REPORTED THAT THE WHOLE ASSEMBLY CAME APART. A SECOND PROTÉGÉ GPS STENT WAS USED TO COMPLETE THE PROCEDURE. IT WAS REPORTED THAT SIMILAR ISSUES WERE ENCOUNTERED WITH THE SECOND STENT ALSO, BUT THAT THE PHYSICIAN MANAGED TO SUCCESSFULLY DEPLOY THE STENT. NO PATIENT INJURY WAS REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6574260 ↗MalfunctionMay 17, 2017Detachment of Device or Device Component; Detachment of Device or Device Component
THE PHYSICIAN WAS ATTEMPTING TO USE A PROTÉGÉ GPS STENT TO TREAT AN UNKNOWN LESION. THE DEVICE WAS PREPPED AS PER IFU WITHOUT ISSUE. NO RESISTANCE WAS ENCOUNTERED WHEN ADVANCING THE DEVICE AND NO EXCESSIVE FORCE WAS USED THE THUMBSCREW/LOCK-PIN WAS CHECKED FOR MEASUREMENT PRIOR TO PROCEDURE. PRIOR TO ATTEMPTING TO DEPLOY THE STENT, WHEN UNSCREWING THE PIN PULL DEPLOYMENT, IT WAS REPORTED THAT THE WHOLE ASSEMBLY CAME APART. A SECOND PROTÉGÉ GPS STENT WAS USED TO COMPLETE THE PROCEDURE. IT WAS REPORTED THAT SIMILAR ISSUES WERE ENCOUNTERED WITH THE SECOND STENT ALSO, BUT THAT THE PHYSICIAN MANAGED TO SUCCESSFULLY DEPLOY THE STENT. NO PATIENT INJURY WAS REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6574257 ↗
Other STENT, ILIAC devices
- Cordis S.M.A.R.T. Control Vascular Stent System C10040MLCordis US Corp. · STENT, ILIAC1 recall3 reports
- Absolute Pro 1012534-100Abbott Vascular Inc. · STENT, ILIAC51 reports
- Protégé™ GPS™ SERB65-09-60-80Ev3, Inc · STENT, ILIAC1 recall0 reports
- Cordis S.M.A.R.T. Control Vascular Stent System C09060MLCordis US Corp. · STENT, ILIAC1 recall0 reports
- Absolute Pro 1012535-100Abbott Vascular Inc. · STENT, ILIAC1 death41 reports
- Omnilink Elite 1012631-39Abbott Vascular Inc. · STENT, ILIAC27 reports
- Omnilink Elite 1012632-29Abbott Vascular Inc. · STENT, ILIAC25 reports
- Absolute Pro 1012536-100Abbott Vascular Inc. · STENT, ILIAC21 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page